Pravastatin for Primary Prevention in Older Adults: Restricted Mean Survival Time Analysis.

Ariela R OrkabyMichael W RichRyan SunEliah LuxLee-Jen WeiDae Hyun Kim

Published in: Journal of the American Geriatrics Society (2018)

RMST provides an intuitive and explicit way to express the effect of pravastatin therapy on CHD-free and overall survival in older adults free of cardiovascular disease. This measure allows a more personalized interpretation than hazard ratios of the benefits and risks of a medical intervention for decision-making.

Keyphrases

cardiovascular disease
decision making
physical activity
randomized controlled trial
free survival
healthcare
human health
risk assessment
mesenchymal stem cells